HNC364 Injectable Suspension

HNC364 · Guangzhou Henovcom Bioscience Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HNC364 Injectable Suspension, covering 2024-09-27 to 2025-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Relative Bioavailability Study of HNC364 Injectable Suspension [Phase 1]